Clinical Trials on Acne Vulgaris and Rosacea in Norway

Total 14 results

Photocure

Completed

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne

Acne Vulgaris

United States
Dow Pharmaceutical Sciences

Completed

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Acne Vulgaris

United States
Fougera Pharmaceuticals Inc.

Completed

A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Dose Range Study of CD5789 in Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

Acne Vulgaris

United States, Canada
Vyne Therapeutics Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris

Acne Vulgaris

United States
Braintree Laboratories

Completed

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Phase 3 Papulopustular Rosacea Study

Papulopustular Rosacea (PPR)

United States, Canada
Arctic Nutrition AS
University of Bergen; Haukeland University Hospital

Completed

Clinical Study to Investigate Psorax35 Supplementation in Patients With Psoriasis

Psoriasis Vulgaris

Norway
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Vyne Therapeutics Inc.

Completed

A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

Papulopustular Rosacea

United States
Sienna Biopharmaceuticals

Completed

Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris

Pruritus | Psoriasis Vulgaris

United States
ChemoCentryx

Completed

Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)

Hidradenitis Suppurativa | Acne Inversa

United States

3

Subscribe